Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001641172-25-007884
Filing Date
2025-04-30
Accepted
2025-04-30 17:13:07
Documents
16
Period of Report
2025-04-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A formdef14a.htm   iXBRL DEF 14A 611918
2 GRAPHIC formdef14a_001.jpg GRAPHIC 9896
  Complete submission text file 0001641172-25-007884.txt   950738

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE rnxt-20241231.xsd EX-101.SCH 3416
4 XBRL DEFINITION FILE rnxt-20241231_def.xml EX-101.DEF 5343
5 XBRL LABEL FILE rnxt-20241231_lab.xml EX-101.LAB 53093
6 XBRL PRESENTATION FILE rnxt-20241231_pre.xml EX-101.PRE 41480
19 EXTRACTED XBRL INSTANCE DOCUMENT formdef14a_htm.xml XML 2094
Mailing Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040
Business Address 2570 W. EL CAMINO REAL, STE. 320, MOUNTAIN VIEW CA 94040 408-800-2649
RenovoRx, Inc. (Filer) CIK: 0001574094 (see all company filings)

EIN.: 271448452 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-40738 | Film No.: 25897445
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)